Program
Acne mRNA vaccine
Its studies are mostly in Acne Vulgaris, led by Sanofi.
Furthest: phase 2, since Mar 12, 20242 company-led studies, 2 open or runningNext primary completion: Nov 30, 2028 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sanofi | 22 open or running | phase 2since Mar 12, 2024 | Mar 12, 2024 | Nov 30, 2028phase 2 · NCT06316297 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 12, 2024First study: phase 2 study in Acne VulgarisFirst studyNCT06316297 · 800 planned · United States, Australia, Canada and more
- Jun 2, 2025Phase 2 study in Acne VulgarisNCT07013747 · 228 planned · United States
Ahead
- Nov 30, 2028Primary completion: phase 2 study in Acne VulgarisNCT06316297
- Jun 19, 2029Primary completion: phase 2 study in Acne VulgarisNCT07013747
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“Acne mRNA vaccine”name, by rule
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07013747Acne Vulgaris · United States | 2 | Recruiting | Jun 19, 2029 | 228 |
| NCT06316297Acne Vulgaris · United States, Australia, Canada and more | 2 | Recruiting | Nov 30, 2028 | 800 |
How it is read
Names in the registry
- “Acne mRNA vaccine”, 2 entries
Conditions, from the studies’ own filings
- Acne Vulgaris, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.